R Esteban Selected Research

R Esteban Research Topics

Disease

22	Chronic Hepatitis C 11/2017 - 01/2000
18	Infections 08/2020 - 04/2000
11	Chronic Hepatitis B 11/2017 - 09/2000
10	Fibrosis (Cirrhosis) 11/2017 - 01/2000
6	Hepatitis C 08/2020 - 05/2000
5	Hepatitis B 11/2017 - 01/2001
5	Hepatitis 02/2006 - 09/2000
4	Liver Cirrhosis (Hepatic Cirrhosis) 07/2012 - 01/2000
4	Liver Diseases (Liver Disease) 07/2010 - 04/2000
3	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 03/2001
2	Thyroid Neoplasms (Thyroid Cancer) 10/2008 - 08/2008
2	Hemorrhage 11/2007 - 01/2000
2	Liver Failure 05/2006 - 11/2001
2	Hepatic Encephalopathy 11/2001 - 11/2001
2	Viremia 08/2001 - 05/2000
2	Hepatitis A (Hepatitis, Infectious) 01/2001 - 09/2000
1	HIV Infections (HIV Infection) 07/2012
1	Hemolysis 01/2012
1	Human Influenza (Influenza) 01/2012
1	Hyperthyroidism 10/2008
1	Neoplasms (Cancer) 08/2008
1	Thrombocytopenia (Thrombopenia) 11/2007
1	Cystinosis 01/2007
1	Ocular Hypertension (Glaucoma, Suspect) 01/2005
1	Uveal melanoma 01/2005
1	Bacterial Infections (Bacterial Infection) 07/2003
1	Ascites 07/2003
1	Necrosis 07/2003
1	Peritonitis 03/2003
1	Body Weight (Weight, Body) 03/2003
1	Chronic Hepatitis (Chronic Active Hepatitis) 11/2001
1	Brain Edema (Cerebral Edema) 11/2001
1	Coinfection 08/2001
1	End Stage Liver Disease 04/2001
1	Hemoperitoneum 03/2001
1	Hypertension (High Blood Pressure) 02/2001
1	Anemia 04/2000
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2000

Drug/Important Bio-Agent (IBA)

15	Ribavirin (Virazole)FDA LinkGeneric 11/2017 - 01/2000
14	InterferonsIBA 11/2017 - 01/2000
8	Lamivudine (Epivir)FDA Link 04/2015 - 04/2001
7	RNA (Ribonucleic Acid)IBA 07/2012 - 04/2000
6	Antiviral Agents (Antivirals)IBA 08/2020 - 05/2002
6	Hepatitis B e AntigensIBA 11/2017 - 06/2005
6	DNA (Deoxyribonucleic Acid)IBA 07/2010 - 04/2001
4	Interferon-alpha2bIBA 05/2002 - 04/2000
3	SofosbuvirIBA 11/2017 - 06/2016
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2017 - 05/2002
3	lipoarabinomannan (LAM)IBA 04/2015 - 09/2007
2	daclatasvirIBA 11/2017 - 06/2016
2	AntigensIBA 11/2017 - 04/2001
2	Immunoglobulin G (IgG)IBA 07/2012 - 09/2000
2	Alanine Transaminase (SGPT)IBA 07/2012 - 01/2001
2	adefovirIBA 09/2009 - 09/2007
2	EnzymesIBA 05/2006 - 07/2003
2	peginterferon alfa-2b (Pegintron)FDA Link 03/2004 - 03/2003
2	Transaminases (Aminotransferases)IBA 05/2002 - 12/2001
2	Glutamine (L-Glutamine)FDA Link 11/2001 - 11/2001
2	Hepatitis A AntibodiesIBA 01/2001 - 09/2000
2	AntibodiesIBA 09/2000 - 03/2000
1	velpatasvirIBA 11/2017
1	sofosbuvir drug combination ledipasvirIBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 04/2015
1	hepatitis B hyperimmune globulinIBA 04/2015
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 07/2013
1	Anti-Idiotypic AntibodiesIBA 07/2012
1	LDL CholesterolIBA 05/2012
1	InterleukinsIBA 05/2012
1	Triglycerides (Triacylglycerol)IBA 05/2012
1	oxidized low density lipoproteinIBA 05/2012
1	LipidsIBA 05/2012
1	Oseltamivir (Tamiflu)FDA Link 01/2012
1	adefovir dipivoxil (Hepsera)FDA Link 02/2006
1	Indicators and Reagents (Reagents)IBA 01/2005
1	Messenger RNA (mRNA)IBA 07/2003
1	CytokinesIBA 07/2003
1	Interleukin-6 (Interleukin 6)IBA 07/2003
1	Proteins (Proteins, Gene)FDA Link 07/2003
1	Prothrombin (Factor II)IBA 07/2003
1	BilirubinIBA 07/2003
1	Norfloxacin FDA Link 03/2003
1	QuinolonesIBA 03/2003
1	Interferon alpha-2 (Roferon-A)FDA Link 11/2001
1	Inositol (Myoinositol)IBA 11/2001
1	AmmoniaIBA 11/2001
1	Immunoglobulin M (IgM)IBA 01/2001
1	A-factor (Streptomyces)IBA 10/2000
1	Ferritins (Ferritin)IBA 08/2000
1	Interferon-alpha (Interferon Alfa)IBA 08/2000
1	Intravenous Immunoglobulins (IVIG)FDA Link 04/2000

Therapy/Procedure

26	Therapeutics 11/2017 - 01/2000
7	Liver Transplantation 01/2017 - 02/2001
1	Aftercare (After-Treatment) 05/2012
1	Salvage Therapy 09/2009
1	Operative Surgical Procedures 11/2007
1	Platelet Transfusion (Blood Platelet Transfusions) 11/2007
1	Transplantation 07/2003
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 11/2001
1	Emergency Treatment 03/2001
1	Duration of Therapy 10/2000